The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 1 - Coronary artery bypass grafting surgery
D.M. Shahian, S.M. O'Brien, G. Filardo The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1 - coronary artery bypass grafting surgery Ann Thorac Surg 88 1 Suppl 2009 S2 S22
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 2 - Isolated valve surgery
S.M. O'Brien, D.M. Shahian, G. Filardo The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2 - isolated valve surgery Ann Thorac Surg 88 1 Suppl 2009 S23 S42
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 3 - Valve plus coronary artery bypass grafting surgery
D.M. Shahian, S.M. O'Brien, G. Filardo The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3 - valve plus coronary artery bypass grafting surgery Ann Thorac Surg 88 1 Suppl 2009 S43 S62
Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): A randomised placebo-controlled trial
S. Giri, C.M. White, A.B. Dunn Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial Lancet 357 2001 830 836
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early after Revascularization, Valve Replacement, or Repair: PAPABEAR: A randomized controlled trial
L.B. Mitchell, D.V. Exner, D.G. Wyse Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial JAMA 294 2005 3093 3100
National Quality Forum Report http://www.qualityforum.org/Measuring- Performance/Improving-NQF-Process/Evidence-Task-Force-Final-Report.aspx Accessed: July 13, 2011